ExxonMobil's Board Elects Kenneth C. Frazier
Exxon Mobil Corporation announced today that shareholders elected Kenneth C. Frazier to its board of directors. Mr. Frazier is currently Executive Vice President and President, Global Human Health, at Merck & Co., Inc.
With Mr. Frazier's election, the ExxonMobil board stands at ten directors, nine of whom are non-employee directors. Mr. Frazier will serve on the Board Affairs and Public Issues and Contributions Committees.
Mr. Frazier was appointed to his current position in 2007. In this role, he leads marketing and sales functions for Merck's pharmaceutical and vaccine businesses worldwide.
Since joining Merck in 1992, Mr. Frazier has held a number of key leadership positions including serving as Senior Vice President and General Counsel from 1999 to 2006. Prior to Merck, Mr. Frazier was a partner with the Philadelphia firm of Drinker Biddle & Reath. Mr. Frazier has been recognized with multiple awards for his personal pro bono legal work.
Mr. Frazier, 54, earned a B.A. in Political Science from Pennsylvania State University in 1975 and a J.D. from Harvard Law School in 1978.
Operates 16 Offshore Rigs
- ExxonMobil Reports Papua New Guinea Discovery (Jan 16)
- Exxon, BP Targeted in NYC Suit That Relies on 'Nuisance' Theory (Jan 10)
- ExxonMobil Reports More Offshore Guyana Success (Jan 05)